Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

April 27, 2020 Issue

09816-cover-opener.jpg

April 27, 2020 Cover

Volume 98, Issue 16

The coronavirus pandemic may mark a rebalancing of where drugs are made as nations recognize a security imperative

Cover image:The COVID-19 pandemic may mark a rebalancing of the drug supply chain as nations recognize a security imperative


Credit: Will Ludwig/C&EN/Shutterstock

Full Article
Volume 98 | Issue 16

All Issues

Outsourcing

COVID-19 is reshaping the pharmaceutical supply chain

The coronavirus pandemic may mark a rebalancing of the drug supply chain as nations recognize a security imperative

  • Science editor in chief Holden Thorp on the role of science during the COVID-19 pandemic

    The chemist and former university administrator uses editorials to speak up for science during an ‘extraordinary’ time

  • To improve safety, Camille Peres couples psychology to process design

    People are too complicated for one-size-fits-all communication, she says

  • Periodic Graphics: How does immunity work?

    Chemical educator and Compound Interest blogger Andy Brunning explains how our bodies fight foreign invaders like coronaviruses

ADVERTISEMENT
image name
Economy

US chemical output to drop this year

Novel coronavirus shutdown is choking demand for chemicals as well as investment, key trade group says

ADVERTISEMENT
ADVERTISEMENT